DO NOT RELEASE IN THE UNITED STATES OR THROUGH US NEWSWIRE
VANCOUVER, BC / ACCESSWIRE / September 27, 2021 / CanaFarma Hemp Products Corp. (CSE: CNFA) (the “Society” Where “CanaFarma“) a leader in branded health and wellness, announces that its strategic partner, Winners Circle Genetics, Inc. (“WCG“), achieved its first product” drop “since the Company entered into its terms sheet with WCG (for details, see the Company’s press release dated August 10, 2021).
The first drop was the purchase by WGC (through the use of its working capital with CanaFarma) of approximately $ 185,000 of inventory of its exotic and exclusive cannabis varieties, its two previously marketed varieties Peanut Butter & Jelly and Birkinz being fully sold. in less than six weeks from the time of inventory purchase. Products under the last strain of WGC, 1942, were delivered later than the first two, arriving in dispensaries in early September. Sales of this strain have shown similar uptake as the first two strains sold to date.
Vitaly Fargesen, Senior Vice President of Strategy for CanaFarma added: âWe are extremely happy to see the success of this first drop by the Winners Circle. Being sold out in just 6 weeks is a great testament to the quality of their products and a start to our relationship with the Winner’s Circle. “
About Winners Circle Genetics, Inc.
Winner’s Circle Genetics is one of the leading genetics companies in the cannabis industry. WCG’s world-class, exclusive and premium cannabis brands have taken the industry by storm with their award-winning strains.
About CanaFarma Hemp Products Corp.
CanaFarma Hemp Products Corp. is a full service company operating in the hemp industry providing a full line of hemp related products and services to the consumer welfare market. These products and services include growing high quality hemp, providing hemp processing services and offering hemp products to consumers using a well established direct marketing approach.
For media inquiries, please contact:
This press release contains statements and information which, to the extent that they are not historical facts, may constitute âforward-looking informationâ within the meaning of applicable securities laws. Forward-looking information may include financial and other projections, as well as statements regarding future economic plans, objectives or performance, or the assumption underlying all of the foregoing. In some cases, forward-looking statements may be identified by words such as “could”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “have the “intention”, “plan”, “forecast”, “project”, “estimate”, “prospect” or the negative thereof or other similar expressions concerning matters which are not historical facts. Examples of such statements include, but are not limited to, sales of products by WGC, future supply and demand for WGC products. Forward-looking information is based on the assumptions, estimates, analyzes and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management considers relevant. and reasonable in the circumstances on the date such statements are made, but which may prove to be inaccurate.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the Company. forward-looking information. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: funding risks; regulatory and licensing risks; changes in consumer demand and preferences; changes in economic, trade and general political conditions, including changes in financial markets; risks related to regulatory changes; compliance with extensive government regulations; public opinion; the impact of COVID-19; and the risk factors set out in the Company’s public documents filed with Canadian securities regulatory authorities and available on the Company’s profile on SEDAR at www.sedar.com. If one or more of these risks or uncertainties materialize, or if the assumptions underlying the forward-looking information turn out to be incorrect, actual results could differ materially from those described herein as intended, planned, anticipated, believed, estimated. or expected. Therefore, readers should not place undue reliance on this forward-looking information. In addition, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the management of the Company to predict all of these factors and to assess in advance the impact of each of these factors on the business of the Company or the extent to which any factor, or a combination of factors, could cause actual results to differ materially from those contained in any forward-looking information.
The Company assumes no obligation to update forward-looking information to reflect information or events subsequent to the date on which it is made or to reflect the occurrence of unforeseen events, except as required by law, including securities laws.
THE SOURCE: CanaFarma Hemp Products Corp.
See the source version on accesswire.com: